Pancreatic cancer treated with CT, a selective STAT3 inhibitor, and Gefitinib (EGFR inhibitor) also showed encouraging results with the lowest time capable of inducing cell death in all eight pancreatic cancer cells examined. Here, STAT3 is linked to familial pancreatic carcinoma.